Monday, November 26, 2007

Own It: Transforming Public Perception of Pharma through Better Sales & Marketing Practices

Date: 11/14/2007
Length: 00:12:40
Size: 5.79MB

Thought Leaders: Michael Ball, Ph.D., VP, Marketing and Product Management, InfoMedics, and Paul LeVine, VP, Analytical Services, InfoMedics

In this episode, Dr. Ball and Mr. LeVine talk about three key areas of brand management: public perception, principal stakeholders, and technology in sales and marketing practices.

Play full podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Monday, October 29, 2007

Precommercial Marketing and Planning: Laying the Ground Work for Future Success

Date: 10/23/2007
Length: 00:14:53
Size: 6.81MB


Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing

Ms. Lucas provides details on how to develop an informed view of the market for your brand during the precommercialization phase. The discussion covers the risks for not doing so, the benefits of a prelaunch strategy, and the tactics for ultimate success.

Play Full Podcast

Download the whitepaper (Requires Acrobat PDF Reader)

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Monday, September 10, 2007

Competitive Simulations: The New, Improved War Games

Date: 9/7/2007
Length: 00:12:57
Size: 5.93MB
Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC

Dr. Bernard highlights the differences between competitive simulations and traditional business war games and discusses how customized competitive simulation exercises can provide strategic advantages for pharmaceutical brands and brand teams.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thursday, August 30, 2007

The Brave New Real World: A Changing Paradigm for Documenting Product Value and Safety Postapproval

Date: 8/29/2007
Length: 00:15:30
Size: 6.96MB
Thought Leader: Jeff Trotter, Senior VP, Lifecycle Sciences Group, Icon Clinical Research

Jeff Trotter speaks about the need for real-world value and safety in postmarketing research, the current landscape, designing new studies, and how the industry can leverage opportunities in the postapproval environment.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

ePRO's Impact on Clinical Trials

Date: 8/27/2007
Length: 00:12:14
Size: 5.60MB
Thought Leader: Jean Paty, Ph.D., Founder and Senior VP, Scientific, Quality and Regulatory Affairs, invivodata

Dr. Paty talks about a defining moment in clinical trial data, how ePRO will revolutionize clinical trials, improving the adoption of ePRO, and the future of clinical data technology.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Incorporating Electronic Health Records in the Trial Process

Date: 8/27/2007
Length: 00:17:54
Size: 8.19MB
Thought Leader: James Rogers, CEO, Nextrials Inc.


Taren Grom, Cofounder and Editor of PharmaVOICE magazine, and James Rogers, CEO of Nextrials, discuss the benefits of incorporating electronic health records (EHR) into the clinical-trial process, what the challenges are, and how EHR can be used in other areas, such as patient recruitment.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Friday, August 17, 2007

Early Adopters Using SAFE Digital Signatures

Date: 6/19/2007
Length: 00:6:49
Size: 3.12MB
Thought Leader: Mollie Shields-Uehling, President and CEO, SAFE Biopharma Association

Dan Limbach, Producer, PharmaVOICE Webcast Network, speaks with Mollie Shields-Uehling, who provides an overview of the SAFE digital signature technology, the benefits of electronic submissions, and which companies are adopting this model.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Trends in Patient Recruitment

Date: 6/19/2007
Length: 00:5:50
Size: 2.67MB
Thought Leader: Bonnie Brescia, Cofounder, BBK Worldwide

Taren Grom, Cofounder and Editor of PharmaVOICE, speaks with Bonnie Brescia about the changing role of the pharmaceutical company in patient recruitment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Managing Chargebacks to Boost the Bottom Line

Date: 8/17/2007
Length: 00:19:23
Size: 8.87MB
Thought Leader: Al Godley, Director of Life-Science Solutions, Edge Dynamics

Al Godley explains the impact that chargebacks have on manufacturers' bottom lines, why chargebacks continue to be a source of silent revenue leakage, and best practices for chargeback management.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Monday, August 13, 2007

Improving Patient Compliance Using Ethnographic Research

Date: 7/26/2007
Length: 00:15:21
Size: 7.02MB
Thought Leader: Stuart Paul, CEO, Communication Science Inc.

Stuart Paul outlines an innovative model that uses ethnographic research and evidence-based communications to achieve better health outcomes.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Translational Connection Model for Creating Infectious Disease Therapies: Part 1

Date: 8/10/2007
Length: 00:16:49
Size: 7.70MB
Thought Leader: Barry Eisenstein, M.D., Senior VP, Scientific Affairs, Cubist Pharmaceuticals

Taren Grom, Cofounder and Editor of PharmaVOICE, and Dr. Eisenstein discuss the concept of a "translational connection" development model and how this shift in thinking can be employed to create new therapies to address unmet medical need in infectious disease in Part 1 of a 2-part series.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Translational Connection Model for Creating Infectious Disease Therapies: Part 2

Date: 8/10/2007
Length: 00:16:10
Size: 7.40MB
Thought Leader: Barry Eisenstein, M.D., Senior VP, Scientific Affairs, Cubist Pharmaceuticals

Taren Grom, Cofounder and Editor of PharmaVOICE, and Dr. Eisenstein discuss how the "translational connection" model can be used in other therapeutic areas and where the next generation of medical/research talent will come from. Part 2 of a 2-part series.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Phase IV Registries and Patient Outcomes

Date: 7/31/2007
Length: 00:14:00
Size: 6.41MB
Thought Leader: Nancy Dreyer, MPH, Ph.D., Chief of Scientific Affairs, Outcome

Dr. Nancy Dreyer discusses her involvement in the development of the Registries for Evaluating Patient Outcomes handbook published by the Agency for Healthcare Research and Quality and what some of the significant findings were from the research and how these data can positively impact patient outcomes.

test
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Relationship Networking and Monitoring the Influence of Physicians

Date: 7/24/2007
Length: 00:13:42
Size: 6.27MB
Thought Leader: Kelly Myers, CEO, Qforma Inc.

Kelly Myers discusses the concept of relationship networking, what the differences are between an action leader and a thought leader, and how tools from the field of physics can be used to study physician-based data to improve sales and marketing efficiency.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Reintegrating Healthcare and Society

Date: 7/24/2007
Length: 00:13:48
Size: 6.32MB
Thought Leader: Laurie Myers, Ph.D., VP and Client Partner, Business Consulting, Fair Isaac Corp.

Dr. Laurie Myers talks frankly about the bond between healthcare and society and the challenges associated with strengthening this bond moving forward.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Friday, June 22, 2007

EDC and the E-Clinical Space

Date: June 2007
Length: 00:12:14
Size: 5.60MB

Thought Leader: Ronald Kershner, Ph.D., Senior VP, Clinical Operations, inVentiv Clinical Solutions LLC

Dr. Kershner outlines the current state of play of EDC in the industry and the benefits the technology can bring to clinical studies, particularly access to real-time data and cost savings. Dr. Kershner also provides his insights to remaining adoption challenges.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Why Validate?

Date: June 2007
Length: 00:11:39
Size: 5.33MB

Thought Leader: Chris Biddle, VP, Solutions Architecture, GHX Pharma Solutions

Good data validation practices for managed care can make a big impact on a pharmaceutical company's bottom line. This episode covers several important issues on this topic, including the general business environment for validation, why validation is important, Medicare Part D ramifications, primary causes of data errors, the ROI of validation, and more.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thursday, June 21, 2007

Biological Drug Development

Date: June 2007
Length: 00:5:13
Size: 2.39MB

Thought Leader: William J. Newell, Executive VP, Aerovance

Mr. Newell discusses the uses of biologics in the development of asthma treatments, the challenges involved with biologic drug development, and considerations when designing a trial.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Biotechnology Business Trends

Date: June 2007
Length: 00:6:19
Size: 2.89MB

Thought Leader: Kenneth C. Carter, Ph.D., President and CEO, Avalon Pharmaceuticals

Dr. Carter talks about technology trends in the emerging biotechnology space, deal-making at the preclinical level, and Avalon's technology, a high-throughput discovery and development engine that is based on the total breadth of a cell's response at the genomic level to a drug.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Seed Funding

Date: June 2007
Length: 00:3:41
Size: 1.68MB

Thought Leader:Barbara Schilberg, CEO, BioAdvance, Biotechnology Greenhouse of SE Pennsylvania

Ms. Schilberg discusses why it's important to invest in a new generation of life-sciences companies and how her organization is addressing a national problem — the gap in seed funding.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Global Biotechnology Trends


Date: June 2007
Length: 00:4:26
Size: 2.03MB

Thought Leader:Martyn Postle, Chairman and Chief Executive, Cambridge Healthcare & Biotech Ltd.

In this Podcast episode, Mr. Postle provides a top-line overview of global biotechnology trends based on results from a recent report — U.K. Drug Pipeline —completed by Cambridge Healthcare & Biotech.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Partnerships and Funding Opportunities


Date: June 2007
Length: 00:5:09
Size: 2.36MB

Thought Leader:Lucienne Cicurel, Ph.D., External Affairs Director, Debiopharm Group

Dr. Cicurel discusses trends in competition in the oncology space, best practices for partnerships, and funding for development.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Multimechanism Drugs


Date: June 2007
Length: 00:4:26
Size: 2.02MB

Thought Leader:James S. Burns, President and CEO, EntreMed Inc.

Mr. Burns talks about the advantages of multimechanism drugs to solve distinct development challenges in the oncology arena, the complexities of drug development, and the challenges associated with running a biotechnology company.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The State of Biotechnology in Kansas







Date: June 2007
Length: 00:3:56
Size: 1.80MB

Thought Leader: U.S. Senator Pat Roberts, U.S. Senator, Kansas; Tom Thornton, President and CEO, Kansas Biotech Authority, and Angela Krupps, President, Kansas BIO

State representatives discuss Kansas' biotechnology initiatives — health, agro, and biofuels — and what these mean to the state's economy.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Macromolecule Development Trends






Date: June 2007
Length: 00:6:47
Size: 3.10MB

Thought Leader:Timothy Duffy, Executive VP, Marketing and Business Development, Nastech Pharmaceutical Co.

Mr. Duffy discusses how macromolecules — peptides and protein therapeutics — are expanding opportunities for development, partnering, therapeutic focus, and delivery of compounds.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

New R&D Model







Date: June 2007
Length: 00:12:56
Size: 5.92MB

Thought Leader: Jeff Davis, Head, Global New Business Development, and Kevin Driscoll, Ph.D., Director, Global New Technology Development, P&G Pharmaceuticals Inc.

Mr. Davis and Dr. Driscoll reveal P&G's outsourcing strategy for drug development, therapeutic areas of concentration, partnering strategies, and how the biotechnology component factors into the model.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Integrated Development Strategies




Date: June 2007
Length: 00:6:51
Size: 3.13MB

Thought Leader: Stephen Keith Rhind, Ph.D., Senior VP, S*BIO Pte Ltd.

Dr. Rhind talks about the advantages of having integrated development capabilities, being based in Singapore in terms of patient recruitment, and the challenges involved in moving from discovery to development from a commercial perspective.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Hot Trends in the Biotech Sector




Date: June 2007
Length: 00:4:53
Size: 2.23MB

Thought Leader: Scott Ballenger, R.Ph., President, Trial Acceleration Institute

Mr. Ballenger discusses the hot trends in the biotech sector, such as the global nature of the industry, innovation, and what the promise of the industry holds.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Tuesday, May 01, 2007

Leadership Development with the HBA





Date: May 2007
Length: 00:16:27
Size: 7.53MB

Thought Leader: Cathy Kerzner, President, Healthcare Businesswomen's Association

Cathy Kerzner discusses the HBA's goals for the year, the importance of setting a personal leadership agenda, and the importance of being an HBA Rising Star, with Taren Grom Editor of PharmaVOICE. In addition, Ms. Kerzner outlines the many ways the global organization can foster career development in the life sciences. Please see the Special Feature article in the May issue of PharmaVOICE showcasing all of the 2007 HBA Rising Stars.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Industry Solutions for Improving Public Health






Date: May 2007
Length: 00:14:57
Size: 6.84MB

Thought Leaders: Michael Ball, Ph.D., VP, Marketing and Product Management, InfoMedics, and Paul LeVine, VP, Analytical Services, InfoMedics

This episode covers several key issues regarding the role pharmaceutical companies play in the public-health sector, including the importance of communicating with stakeholders, the need to support patients through education, and where the industry, as a whole, is going.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Pharma's Expanding Role in Public Health

Date: May 2007
Length: 00:14:23
Size: 6.59MB

Thought Leader: Barbara DeBuono, M.D., MPH, Senior Medical Advisor, U.S. Public Health and Policy, Pfizer Global Pharmaceuticals, Pfizer Inc.

There is no shortage of challenges regarding public health in the United States. In this Podcast episode, Dr. DeBuono discusses the impact the pharmaceutical industry can have on public health, talks about what pharma companies should be doing over the next five years, and provides some advice for developing talent in the public health sector.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Monday, April 16, 2007

eClinical Integration

Date: April 2007
Length: 00:11:34
Size: 5.29MB

Thought Leader: Steve Kent, CEO, ClinPhone, Nottingham, UK

New technologies will play a key role in accelerating and transforming the drug-development process. In this Podcast episode, Steven Kent, CEO of ClinPhone, discusses the challenges and solutions involved with integrating different electronic systems, the barriers to adoption, the impact of regulatory standards, and the technology trends that will have the greatest impact on clinical research.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Monday, March 19, 2007

Global Branding, Not Blanding

Date: March 2007
Length: 00:19:24
Size: 8.88MB

Thought Leaders: Rob Rogers, Chief Creative Officer, Sudler & Hennessey, Bruno Stucchi, Global Creative Director, Sudler & Hennessey, Milan, Italy

In this Podcast episode, two advertising executives provide a creative twist as they discuss the next evolution in global pharmaceutical branding. They talk about new approaches to branding on a global scale, why brand managers should think about return on concept rather than return on investment, and ways in which the Internet is providing global marketing opportunities for brands of all sizes.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Tuesday, March 06, 2007

Leadership Development

Date: March 2007
Length: 00:15:54
Size: 7.28MB
Thought Leader: Jonathan E. Lim, M.D., President and CEO, Halozyme Therapeutics

A career in the life sciences can be extremely rewarding. Dr. Lim shares his views and practices for finding and developing talent. He also discusses the value of interpersonal skills, and the effects of globalization on the workforce.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

EDC and After

Date: March 2007
Length: 00:18:14
Size: 8.34MB
Thought Leaders: Dr. Stephen Rhys Thomas, Senior Partner, and John F. Murray, Senior Partner, Procela Partners

Based on Procela Partners' comprehensive research into the EDC landscape, Dr. Thomas and Mr. Murray provide an independent, insiders' review of the latest trends in the EDC market, including a discussion related to convergent strategies for streamlining the adoption cycle for new technologies as well as the challenges vendors and sponsors face in implementing enterprisewide systems. They also provide a provocative preview of the e-clinical landscape after EDC.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Challenges of Pharmacogenomics

Date: 2/1/2007
Length: 00:16:17
Size: 7.45MB
Thought Leader: Brian Spear, Ph.D., Director of Genomic and Proteomic Technologies, Global Pharmaceutical Research and Development — Abbott

Pharmacogenomics is a serious science that has the potential to revolutionize the life sciences. Dr. Spear discusses the myths, misconceptions, trends, and challenges associated with pharmacogenomics and personalized medicine. He also talks about the future of this groundbreaking science.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thursday, January 11, 2007

The Benefits of a Proactive Compliance Program

Date: 1/11/2007
Length: 00:15:24
Size: 7.05MB

Thought Leader: Eric Siegel, VP, Deputy General Counsel, and Chief Compliance Officer, Cephalon Inc.

Discover how to overcome the challenges related to implementing a corporate-wide compliance program as well how compliance programs can help companies achieve their business objectives. These, and other topics, are covered in this informative episode.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Wednesday, January 03, 2007

Compliance Training Options — Build vs. Buy

Date: 12/29/2006
Length: 00:12:17
Size: 5.62MB
Thought Leader: Peter Sandford, Executive VP, NXLevel

With myriad industry, state, and federal regulations and guidances, compliance training has never been more important. Technology provides an efficient delivery mechanism for a company's training courses. This episode outlines the strengths and weaknesses of custom-built and off-the-shelf training solutions, as well as a hybrid approach.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Salesforce Compliance Strategies and Tactics

Date: 12/21/2006
Length: 00:20:02
Size: 9.16MB
Thought Leader: William C. Bertrand Jr., Senior VP, General Counsel, Corporate Compliance, MedImmune Inc.

Sales and marketing compliance is paramount in the pharmaceutical and biotechnology industries and staying current with ever-changing regulations is mandatory. Keeping the salesforce in step with the company's compliance policies is a never-ending process. This episode features best practices, tips, and lessons from a true industry expert.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Tuesday, January 02, 2007

Integrated Data Management and EDC Solutions

Date: 12/11/2006
Length: 00:21:30
Size: 9.84MB

Thought Leader: Glen de Vries, Cofounder and Chief Technology Officer, Medidata Solutions Worldwide

Clinical trials can benefit greatly from standardization, integrated data management, and the right electronic data capture solution. This episode covers a variety of issues that can help you achieve better ROI from the data management tools being used in clinical trials.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Agile Clinical Trials and the Use of Real-Time Data

Date: 11/7/2006
Length: 00:18:14
Size: 8.34MB

Thought Leader: John Hudak, MBA, President and Founder, Criterium Inc.

How does real-time data improve the agility of clinical trials? How can the process be improved through technology? What are the benefits of using real-time data? Are there any obstacles to be overcome? What is the impact of real-time data on sites, sponsors, and CROs? Learn the answers to these and other questions in this informative Podcast episode.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.